Approval · Notice of Compliance 36701 · 2026
ESTRING: Notice of Compliance 36701
Issued January 8, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36701
- Date
- January 8, 2026
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template. Update to the Product Monograph as per advisement letter. Update to Patient Medication Information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESTRING | Not yet assigned | — |
Medicinal ingredients
- ESTRADIOL 2 MG per RING